Licensing deals on generic versions of Roche flu drug aimed at preparing for pandemic Eleven companies will be permitted to develop, manufacture, and supply Xofluza in 129 countries

https://www.statnews.com/pharmalot/2026/09/25/roche-xofluza-influenza-treatment-agreements/ By Ed SilvermanSept. 25, 2026 Pharmalot Columnist, Senior Writer